Our Science
Our Platform
ceDNA
ctLNP
Capsid-Free Manufacturing
Our Portfolio
An Overview
Liver
Retina
Expansion Areas
Our Culture
Who We Are
Leadership
A Shared Vision
Investor Center
Join Us
Blog
News
Contact
Menu
In the news
Press Releases
June 16, 2020
Generation Bio Announces Closing of Initial Public Offering
June 11, 2020
Generation Bio Announces Pricing of Initial Public Offering
March 30, 2020
Generation Bio and Vir Biotechnology to Collaborate on Research to Leverage Scalable Non-Viral Gene Therapy Platform for Durable Production of Monoclonal Antibodies Against Coronavirus That Causes COVID-19
January 10, 2020
Generation Bio Announces $110 Million Series C Financing to Advance Lead Programs for Hemophilia A and PKU
January 10, 2020
Generation Bio to Present at 38th Annual J.P. Morgan Healthcare Conference
2019
October 29, 2019
Generation Bio Welcomes Steven Dowdy, Ph.D., to its Scientific Advisory Board
June 25, 2019
Generation Bio Appoints Katherine Fitzgerald, Ph.D., to its Scientific Advisory Board
May 31, 2019
Generation Bio to Present at Jefferies 2019 Healthcare Conference
March 8, 2019
Generation Bio to Present at the Cowen & Company 39th Annual Health Care Conference
January 4, 2019
Generation Bio to Present at 37th Annual J.P. Morgan Healthcare Conference
2018
December 17, 2018
Generation Bio to Appoint Tom Graney as Chief Financial Officer
November 19, 2018
Generation Bio to Present at the Evercore ISI Healthcare Conference
November 5, 2018
Generation Bio Appoints Antoinette Paone as Head of Regulatory Affairs
October 4, 2018
Generation Bio Appoints Dr. Richard Thompson to its Scientific Advisory Board
July 31, 2018
Generation Bio Appoints Charles Rowland to its Board of Directors
June 7, 2018
Generation Bio Appoints Jeff Jonas M.D. to its Board of Directors
June 5, 2018
Generation Bio to Present at Jefferies 2018 Global Healthcare Conference
May 8, 2018
Generation Bio Expands Leadership Team with Appointment of Sara Den Besten as Head of Human Resources
April 9, 2018
Generation Bio Strengthens Leadership Team with Appointment of Will McCarthy as Chief Business Officer and Jennifer Elliott, Ph.D., J.D., as Head of Legal Affairs and Intellectual Property
February 27, 2018
Generation Bio Announces $100 Million Series B Financing to Advance GeneWaveTM Platform for Re-Dosable Gene Therapy
1
2
Next »
Twitter
Tweets by GenerationBio
Media Contact
media@generationbio.com
Investor Relations Contact
investors@generationbio.com
Follow us on Twitter
Follow us on Linkedin
close
arrow-circle-o-down
arrow-down
bars
ellipsis-v
cross